Almstead Neil Gregory bought PTCT
July 9, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 2,464 shares of PTC Therapeutics, Inc. at $46.54 per share, a transaction worth $114.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,464
Price
$46.54
Total value
$114.7K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after62,763
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.